Código QR (código de barras bidimensional)

Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria

The development of more effective vaccines against Mycobacterium tuberculosis has become a world priority. Previously, we have shown that a recombinant BCG expressing the LTAK63 adjuvant (rBCG-LTAK63) displayed higher protection than BCG against tuberculosis challenge in mice. In order to elucidate...

תיאור מלא

שמור ב:
Principais autores: Carina Carvalho Dos Santos, Dunia Rodriguez, Alex Kanno Issamu, Luciana Cezar De Cerqueira Leite, Ivan Pereira Nascimento
פורמט: Artigo
שפה:Inglês
יצא לאור: Taylor & Francis Group 2020-03-01
סדרה:Human Vaccines & Immunotherapeutics
נושאים:
tuberculosis
vaccine
recombinant bcg
innate immunity
long-term immunity
גישה מקוונת:http://dx.doi.org/10.1080/21645515.2019.1669414
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים